| Title: | Association of intraindividual differences in estimated glomerular filtration rates based on cystatin C and creatinine with dementia: A cohort study of the UK Biobank. |
| Journal: | PLOS ONE |
| Published: | 6 Mar 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41790841/ |
| DOI: | https://doi.org/10.1371/journal.pone.0344566 |
| URL: | http://dx.doi.org/10.1371/journal.pone.0344566 |
Publication 17481
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Dementia is a leading cause of cognitive decline, with Alzheimer's disease (AD) and vascular dementia (VaD) being the most common subtypes. The intraindividual difference between the estimated glomerular filtration rate based on cystatin C and creatinine (eGFRdiff) may serve as an indicator of the overall health status of an individual. However, the relationships between the eGFRdiff and dementia risk, dementia subtypes, dementia-related neuroimaging changes, and cognitive functions remain unclear.</p>
METHODS: This study analysed data from over 450,000 participants in the UK Biobank who were followed for up to 15 years. The estimated glomerular filtration rate based on cystatin C (eGFRcys) and creatinine (eGFRcr) was calculated using the CKD-EPI equation, and eGFRdiff was defined as the difference between these values (eGFRdiff = eGFRcys - eGFRcr). Multivariate Cox regression models were used to evaluate the associations between the eGFRdiff and all-cause dementia (ACD), AD, and VaD, whereas cross-sectional analysis were used to examine the relationship among the eGFRdiff, dementia-related neuroimaging changes, and cognitive functions.</p>
RESULTS: Over a median follow-up of 13.5 years, 8,710 participants developed dementia, including 3,910 with AD and 1,893 with VaD. Each one standard deviation increase in eGFRdiff was associated with a reduced risk of dementia, with hazard ratios (95% confidence intervals) of 0.92 (0.90-0.94) for ACD, 0.94 (0.91-0.98) for AD, and 0.90 (0.85-0.94) for VaD. A negative eGFRdiff was associated with adverse neuroimaging changes, including lower total brain and gray matter volumes and higher white matter hyperintensities. Additionally, a negative eGFRdiff was associated with poorer performance across multiple cognitive domains.</p>
CONCLUSION: A negative eGFRdiff was associated with an increased risk of dementia, adverse neuroimaging outcomes, and cognitive decline. These findings suggest that the eGFRdiff might be considered a potential associative indicator for dementia and cognitive impairment, suggesting potential clinical value in risk assessment and early intervention strategies.</p>
17 Keywords
- Aged
- Aged, 80 and over
- Alzheimer Disease
- Biological Specimen Banks
- Cohort Studies
- Creatinine
- Cross-Sectional Studies
- Cystatin C
- Dementia
- Female
- Glomerular Filtration Rate
- Humans
- Male
- Middle Aged
- Neuroimaging
- UK Biobank
- United Kingdom
7 Authors
- Zhiyi Mao
- Yuwei Peng
- Ruilang Lin
- Xinyue Guo
- Xiaorui Cui
- Yongfu Yu
- Xueying Zheng
1 Application
| Application ID | Title |
|---|---|
| 98410 | The integration of epidemiological and genomic data to examine the relationship between early life exposure and aging-associated health outcomes later in life |
Enabling scientific discoveries that improve human health